DOSSIER · 13F Holders · Q3 2026Healthcare · Biological Products, (No Diagnostic Substances)
RLAY
RELAY THERAPEUTICS INC
278 institutions still hold RELAY THERAPEUTICS INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 75943R102·Biological Products, (No Diagnostic Substances)·278 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
278 institutions reported RLAY in Q3 2026. FMR LLC leads at 15.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 14
258 more holders available. Log in →